1. Metabolic channelling of 5-fluoro-2′-deoxycytidine utilizing inhibitors of its deamination in cell culture;Boothman;Mol. Pharmacol.,1985
2. Protective, tumor-selective dual pathway activation of 5-fluoro-2′-deoxycytidine provided by tetrahydrouridine in mice bearing mammary adenocarcinoma-755;Boothman;Cancer Res.,1987
3. Tumor-selective metabolism of 5-fluoro-2′-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma;Boothman;Cancer Res.,1987
4. Analysis of 5-fluoro-2′-deoxycytidine and 5-trifluoromethyl-2′-deoxycytidine and their related antimetabolites by high-performance liquid chromatograph;Briggle;J. Chromatog.,1986
5. Aspartate transcarbamoylase, interaction with the transition state analogue N-(phosphonacetyl)-L-aspartate;Collins;J. Biol. Chem.,1971